Cross Country Healthcare Inc (CCRN)
14.57
-0.16
(-1.09%)
USD |
NASDAQ |
May 17, 16:00
14.60
+0.02
(+0.17%)
After-Hours: 20:00
Cross Country Healthcare Cash from Financing (Quarterly): -15.65M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -15.65M |
| December 31, 2023 | -6.416M |
| September 30, 2023 | -53.27M |
| June 30, 2023 | -114.87M |
| March 31, 2023 | -46.68M |
| December 31, 2022 | 6.075M |
| September 30, 2022 | -107.66M |
| June 30, 2022 | -17.32M |
| March 31, 2022 | 31.31M |
| December 31, 2021 | 78.22M |
| September 30, 2021 | -12.57M |
| June 30, 2021 | 15.43M |
| March 31, 2021 | 38.00M |
| December 31, 2020 | -2.827M |
| September 30, 2020 | 6.818M |
| June 30, 2020 | -21.40M |
| March 31, 2020 | -4.599M |
| December 31, 2019 | -2.186M |
| September 30, 2019 | -0.735M |
| June 30, 2019 | -5.383M |
| March 31, 2019 | -9.295M |
| December 31, 2018 | -8.176M |
| September 30, 2018 | -7.025M |
| June 30, 2018 | -3.417M |
| March 31, 2018 | -5.149M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.915M |
| September 30, 2017 | 60.53M |
| June 30, 2017 | -1.273M |
| March 31, 2017 | -7.583M |
| December 31, 2016 | -0.548M |
| September 30, 2016 | -1.024M |
| June 30, 2016 | 1.838M |
| March 31, 2016 | -2.43M |
| December 31, 2015 | 7.831M |
| September 30, 2015 | -3.211M |
| June 30, 2015 | -4.043M |
| March 31, 2015 | 2.778M |
| December 31, 2014 | -1.186M |
| September 30, 2014 | -7.294M |
| June 30, 2014 | 44.08M |
| March 31, 2014 | 10.86M |
| December 31, 2013 | 8.322M |
| September 30, 2013 | -0.102M |
| June 30, 2013 | -0.425M |
| March 31, 2013 | -33.86M |
| December 31, 2012 | -1.249M |
| September 30, 2012 | -2.946M |
| June 30, 2012 | -3.662M |
| March 31, 2012 | -2.726M |
| December 31, 2011 | -6.155M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-114.87M
Minimum
Jun 2023
78.22M
Maximum
Dec 2021
-11.79M
Average
-4.991M
Median
Cash from Financing (Quarterly) Benchmarks
| Cardinal Health Inc | 1.031B |
| CEL-SCI Corp | 6.596M |
| AIM ImmunoTech Inc | 0.147M |
| IGC Pharma Inc | -0.001M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.011M |
| Cash from Investing (Quarterly) | -2.21M |
| Free Cash Flow | 195.14M |
| Free Cash Flow Per Share (Quarterly) | 0.1099 |
| Free Cash Flow to Equity (Quarterly) | 3.801M |
| Free Cash Flow to Firm (Quarterly) | 4.138M |
| Free Cash Flow Yield | 38.28% |